Across TCGA pan-cancer cohorts, APRT Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated APRT data layer compared with 26 for mass-spec protein and 5 for mass-spec protein.

The strongest signal is observed in sarcoma (SARC), where higher APRT Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated APRT expression acts as an unfavorable survival marker.

SARC and UCEC are the cancer types where APRT Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	DFS	Median	All	0.121	0.611	.041	6	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: APRT tumor-vs-normal RNA expression · all APRT data types